Tumor Classification using Gene Expression Data — poking at a problem using Fast.AI again
Recently high-throughput RNA sequencing (RNA-seq) has become the dominant method for studying gene expression. Large amount of gene expression data have been generated in the field of cancer genomics, e.g. The Cancer Genome Atlas (TCGA), where gene expression data for 9,784 tumors is available. ARCHS4 — a web resource that provides expression data at the gene and transcript levels — contains recently recomputed TCGA RNA-Seq data that has been processed using the same pipeline to remove batch effects that inadvertently originate from sequencing samples at different laboratories.
In 2017, a paper on classifying tumor samples based on RNA-Seq data has made headlines, see RNA-Seq Blog. The authors classified TCGA RNA-Seq samples into 31 classes with overall accuracy of ~90% using genetic algorithm as the gene/feature selection method and the k-nearest neighbors algorithm.
Here, I have tried to replicate the results of this paper using Fast.AI library for 33 tumor classes with overall accuracy of 93.9%.
In addition to log2(TPM+0.001) expression values computed per gene, I added result of pathway enrichment analysis for 50 Cancer Hallmark pathways as categorical variables.
I used Fast.AI Categorical Embedding, where the creation of embeddings for categorical variables is performed while training the network end-to-end on structured (tabular) data. The embedding captures the relationships between categories better than popular one-hot-encoding.
A simple feed-forward neural network model with two hidden layers is constructed using Fast.AI library. While training, I found that the network needed further regularization and tuned the dropout levels for each layer.
Let’s visualize the performance of our algorithm using confusion matrix:
Confusion matrix from the original paper looks quite similar.
Our mis-classifications as well as misclassifications of the original paper are primarily within the same organ systems, e.g. colon(COAD) and rectal (READ) cancer; stomach (STAD) and esophageal (ESCA) cancer; cervical (CESC) and endometrial (UCEC) cancer.
Fast.AI is an amazing resource, I believe any researcher or a deep learning practitioner should take a closer look at Fast.AI.
Thank you Jeremy Howard and Rachel Thomas for creating this amazing resource!